Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-004817
Filing Date
2023-06-05
Accepted
2023-06-05 17:05:06
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3519
  Complete submission text file 0001562180-23-004817.txt   5441
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O NTELOS HOLDINGS CORP. 1154 SHENANDOAH VILLAGE DRIVE WAYNESBORO VA 22980
Business Address
Vos Ellen O'Connor (Reporting) CIK: 0001534357 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 23993611